Home Cart Sign in  
Chemical Structure| 66-97-7 Chemical Structure| 66-97-7

Structure of Psoralen
CAS No.: 66-97-7

Chemical Structure| 66-97-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Psoralen, an ingredient from Fructus Psoraleae, intercalates with DNA, inhibiting DNA synthesis and cell division and showing anticancer activity.

Synonyms: Ficusin; Furocoumarin; 7H-Furo[3,2-g]chromen-7-one

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Psoralen

CAS No. :66-97-7
Formula : C11H6O3
M.W : 186.16
SMILES Code : O=C1C=CC2=C(O1)C=C(OC=C3)C3=C2
Synonyms :
Ficusin; Furocoumarin; 7H-Furo[3,2-g]chromen-7-one
MDL No. :MFCD00010520
InChI Key :ZCCUUQDIBDJBTK-UHFFFAOYSA-N
Pubchem ID :6199

Safety of Psoralen

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Psoralen

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Caco-2 cells 50 µM 2 hours To investigate the effects of psoralen on the transport of anastrozole in the Caco-2 cell transwell model. Results showed that psoralen increased the absorption of anastrozole and decreased its efflux by inhibiting P-gp activity. Pharm Biol. 2018 Dec;56(1):433-439
Rat skin 2.0% (w/v) 24 hours Evaluate the permeability of psoralen through the skin, showing that the skin deposition of psoralen from the optimized ethosome formulation (ES2) was 6.56-fold higher than that from the tincture. Int J Nanomedicine. 2014 Jan 23;9:669-78
RAW 264.7 macrophages 62.5, 125, 250 µM 24 hours To evaluate the effect of psoralen derivatives on the viability of RAW 264.7 cells, showing no significant differences at concentrations up to 250 μM. Int J Mol Sci. 2022 May 22;23(10):5813.
Rat chondrocytes 0.01, 0.1, 1, 10, 100 µM 24, 48, 72 hours Psoralen increased chondrocyte viability in a dose- and time-dependent manner, promoting chondrocyte proliferation. Int J Mol Med. 2017 Nov;40(5):1377-1384
SMMC7721 hepatoma cells 20–80 µM 24–72 hours Psoralen inhibited proliferation of SMMC7721 in a dose- and time-dependent manner, and promoted apoptosis. Biol Res. 2019 Jul 5;52(1):34
Human synoviocytes 1-100 µM 3 days PSO significantly reversed TNF-α induced up-regulation of MMP13 and ILs synoviocytes in a dose-dependent manner (1 to 20 µM). Int J Biol Sci. 2019 Jan 1;15(1):229-238
Rat chondrocytes 1-100 µM 3 days PSO (10 µM) activated cartilaginous specific ECM expression along with up-regulation of proliferative genes at transcriptional levels. Int J Biol Sci. 2019 Jan 1;15(1):229-238
HepG2 hepatoma cells 10–80 µM 72 hours Psoralen had little effect on HepG2 cell proliferation. Biol Res. 2019 Jul 5;52(1):34
Rat liver microsomes 2 mM 30 minutes To investigate the effects of psoralen on the metabolic stability of anastrozole in rat liver microsomes. Results showed that psoralen significantly decreased the intrinsic clearance rates of anastrozole. Pharm Biol. 2018 Dec;56(1):433-439
Plasmid DNA 0.1-900 µM 30-90 minutes To investigate the effect of psoralen combined with UVA light on plasmid DNA. Results showed that psoralen alone was not toxic, but when combined with UVA light, DNA single-strand breaks increased, leading to a reduction in supercoiled conformation. Int J Mol Sci. 2022 Dec 3;23(23):15233
Rat chondrocytes 1 µM 48 hours Psoralen promoted chondrocyte proliferation by activating the Wnt/β-catenin signaling pathway, upregulating the expression of Wnt-4, Frizzled-2, β-catenin, and cyclin D1, and downregulating GSK-3β expression. Int J Mol Med. 2017 Nov;40(5):1377-1384
Human primary chondrocytes 12 μg/mL 5 days To verify that psoralen inhibits chondrocyte inflammation via an estrogen-like effect. Results showed that psoralen promoted the expression of estrogen target genes CTSD, PGR, and TFF1 and decreased the expression of inflammation-related genes TNF-α, IL-1β, and IL-6. Aging (Albany NY). 2022 Aug 24;14(16):6716-6726
L02 hepatocytes 10–80 µM 72 hours 10–40 μM psoralen had little effect on L02 cell proliferation, while 80 μM psoralen inhibited L02 cell proliferation. Biol Res. 2019 Jul 5;52(1):34
HepG2.2.15 cells 126.4 µM (IC50) 8 days Evaluate the inhibitory effect of psoralen on HBV replication, showing that psoralen inhibits HBV replication in a concentration-dependent manner. Virol Sin. 2022 Apr;37(2):256-265
FaDu cells 0.1-900 µM 90 minutes To investigate the effect of psoralen combined with UVA light on the survival of FaDu cells. Results showed that psoralen alone was not cytotoxic, but when combined with UVA light, cell damage increased depending on psoralen concentration and irradiation time. Int J Mol Sci. 2022 Dec 3;23(23):15233

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Human Graft-versus-host disease (GVHD) patients Extracorporeal photopheresis (ECP) 0.9 μM 8-MOP 10-15 minutes To study the effect of ECP treatment on Akt phosphorylation in T-lymphocytes from GVHD patients, results showed significantly decreased Akt phosphorylation post-treatment. J Biol Chem. 2016 Nov 18;291(47):24364-24376
SD rats MIA-induced osteoarthritis model Intra-articular injection 1 mg/kg Daily for 1 week, and once every three days for another 1 week Following six weeks of PSO treatments to articular cartilage osteoarthritis, compared to MIA-induced group, the appearance and physiological structure of articular cartilage was more integrated with greatly organized chondrocytes and abundant cartilage matrix. Int J Biol Sci. 2019 Jan 1;15(1):229-238
New Zealand rabbits OA animal model induced by anterior cruciate ligament transection (ACLT) Joint cavity injection 1 mg/mL, 0.1 mL/kg Once a week, total of 5 times To verify the therapeutic effect of psoralen on rabbit OA. Results showed that the psoralen group had less cartilage tissue destruction, decreased OARSI scores, increased subchondral bone mineral density (BMD), trabecular thickness and number, and decreased trabecular separation. Aging (Albany NY). 2022 Aug 24;14(16):6716-6726
Male Sprague Dawley rats Rat skin model Topical administration 2.0% (w/v) Single dose, continued for 10 hours Evaluate the release of psoralen from ethosomes in vivo using microdialysis, showing significantly higher drug concentration in the skin compared to the tincture. Int J Nanomedicine. 2014 Jan 23;9:669-78
Male Sprague-Dawley rats No specific model Oral gavage 20 mg/kg/day Once daily for 10 days To investigate the effects of psoralen pretreatment on the pharmacokinetics of anastrozole in rats. Results showed that psoralen significantly increased the systemic exposure of anastrozole. Pharm Biol. 2018 Dec;56(1):433-439

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.37mL

1.07mL

0.54mL

26.86mL

5.37mL

2.69mL

53.72mL

10.74mL

5.37mL

References

 

Historical Records

Categories